🇺🇸 Prismocitrate 18 in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 10
Most-reported reactions
- Contraindication To Medical Treatment — 5 reports (50%)
- General Physical Health Deterioration — 5 reports (50%)
Frequently asked questions
Is Prismocitrate 18 approved in United States?
Prismocitrate 18 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Prismocitrate 18 in United States?
Vantive Health LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.